Keiretsu Forum Mid Atlantic
Angel Group/Syndicate
Active
Atlantic Mine, United States
11
3M
10
0.85
3
0.09
1
- Areas of investment
Summary
In 2010 was created Keiretsu Forum Mid Atlantic, which is appeared as Corporate Investor. The company was established in North America in United States. The main department of described Corporate Investor is located in the Atlantic Mine.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Keiretsu Forum Mid Atlantic, startups are often financed by Cystic Fibrosis Foundation, Next Act Fund, Connecticut Innovations. The meaningful sponsors for the fund in investment in the same round are Wing Venture Capital, Viking Global Investors, Robin Hood Ventures. In the next rounds fund is usually obtained by SoundBoard Venture Fund, Robin Hood Ventures.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2019. The average startup value when the investment from Keiretsu Forum Mid Atlantic is 5-10 millions dollars. Considering the real fund results, this Corporate Investor is 20 percentage points more often commits exit comparing to other organizations.
Among the most popular fund investment industries, there are Medical, Business Intelligence. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Laurent Pharmaceuticals. For fund there is no match between the location of its establishment and the land of its numerous investments - Canada.
The current fund was established by Vincent Leusner.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 0.85
- Follow on index
- 0.09
- Investments by industry
- Biotechnology (5)
- Medical (4)
- Health Care (4)
- Analytics (3)
- Pharmaceutical (3) Show 19 more
- Investments by region
-
- United States (9)
- Israel (1)
- Canada (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 12M
- Group Appearance index
- 0.82
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.39
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Astarte Medical | 07 May 2019 | Analytics, Health Care, Health Diagnostics, Medical, Predictive Analytics | Early Stage Venture | 5M | United States, Pennsylvania |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.